 Therefore investigators are now trying to identify the effects of G-CSF for refractory AML patients in salvage chemotherapy setting regarding the duration of neutropenia and admission, incidence of infectious complications and the duration of antibiotics application. Furthermore, overall response rate CRCRi after salvage chemotherapy and survival outcomes will be calculated according to G-CSF use. 